Charles Schweizer
Charles Schweizer publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, Ovarian cancer diagnosis and treatment and HER2/EGFR in Cancer Research.
- World rank
- #2,622,521 of 7,710,434 ranked researchers
- Rank in United States
- #768,201 of 1,627,098
- Works
- 30
- Citations
- 925
- Citations per work
- 30.8
What does Charles Schweizer research?
Charles Schweizer's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1550.4%
- Medicine1550.4%
- Everything else1135.9%
- Life Sciences413.7%
- 1Oncology20% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Molecular Biology8% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Reproductive Medicine8% of their works
- 6Biotechnology6% of their works
Research topics
Which keywords describe Charles Schweizer's research?
The keywords of their largest research topics: Chemotherapy, Glycosylation, Metastasis, Immunotherapy, Fc Receptors, Genomic Analysis, Ovarian Cancer and Therapeutic Antibodies.
- Tissue Inhibitors of Metalloproteinases
- Glycans
- Cancer
- BAP1 mutations
- Bacterial Therapy
- Breast Cancer
- Therapeutic Antibodies
- Genomic Analysis
- Immunotherapy
- Glycosylation
- Chemotherapy
- Metastasis
- Fc Receptors
- Ovarian Cancer
- Angiogenesis
- HER2
- Tumor Targeting
- Malignant Pleural Mesothelioma
- Fibroblast Activation Protein
- Matrix Metalloproteinases
- Tumor Microenvironment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy132 topics
- Glycosylation102 topics
- Metastasis102 topics
- Immunotherapy92 topics
- Fc Receptors71 topic
- Genomic Analysis71 topic
- Ovarian Cancer71 topic
- Therapeutic Antibodies71 topic
- Angiogenesis62 topics
- Breast Cancer61 topic
- HER261 topic
- Bacterial Therapy51 topic
- Tumor Targeting51 topic
- BAP1 mutations41 topic
- Malignant Pleural Mesothelioma41 topic
- Cancer31 topic
- Fibroblast Activation Protein31 topic
- Glycans31 topic
- Matrix Metalloproteinases31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
- Tumor Microenvironment31 topic
Where does Charles Schweizer work?
Charles Schweizer's main affiliation in the publication record is Morphotek (United States), United States.
How many publications and citations does Charles Schweizer have?
OpenAlex counts 30 works and 925 citations for Charles Schweizer, an h-index of 16, ranking #2,622,521 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Charles Schweizer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.